Daicel (4202) AI Stock Analysis

• Market Cap: $352.46B
• Dividend Yield: 4.53%
• Average Volume (3M): 536.76K
• Price to Earnings (P/E): 8.4
• Beta (1Y): 1.03
• Revenue Growth: -0.48%
• EPS Growth: -35.29%
• Country: JP
• Employees: 11,134
• Sector: Basic Materials
• Sector Strength: 58
• Industry: Chemicals - Specialty
• EPS (TTM): 34.61
• Shares Outstanding: 266,942,700
• 10 Day Avg. Volume: 480,400
• 30 Day Avg. Volume: 536,760
• PEG Ratio: -0.88
• Price to Book (P/B): 0.98
• Price to Sales (P/S): 0.60
• P/FCF Ratio: 15.09
• Enterprise Value/Market Cap: 1.61
• Enterprise Value/Revenue: 0.98
• Enterprise Value/Gross Profit: 3.52
• Enterprise Value/Ebitda: 4.45
• 1Y Price Target: $1,384.99
• Price Target Upside: 10.58% Upside
• Rating Consensus: Hold
• Number of Analyst Covering: 1
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 80 Outperform
• Price Target: ¥1,515.00 ▲(20.96% Upside)

Daicel's strong financial performance and attractive valuation are the primary drivers of its overall score. While technical indicators suggest some short-term bearishness, the stock's low P/E ratio and high dividend yield provide significant upside potential. The absence of earnings call data and corporate events does not impact the score.

Daicel Business Overview & Revenue Model

Company Description

Daicel Corporation (4202) is a Japanese multinational company specializing in the production of chemicals, plastics, and advanced materials. The company operates primarily in sectors such as automotive, healthcare, and electronics, offering a wide range of products including automotive safety systems, pharmaceutical ingredients, and specialty chemicals. Daicel is known for its commitment to innovation and sustainability, leveraging advanced technology to develop high-performance materials and solutions that meet the needs of various industries.

How the Company Makes Money

Daicel generates revenue through several key streams, primarily from the manufacturing and sale of its chemical products and materials. The company has a strong presence in the automotive sector, providing essential components such as airbags and safety systems, which are critical for vehicle manufacturers. Additionally, Daicel earns revenue from its pharmaceutical business, supplying active pharmaceutical ingredients (APIs) and excipients for drug formulation. The company also benefits from partnerships with major automotive and electronics firms, enhancing its market reach and enabling collaborative innovations. Factors contributing to its earnings include global demand for safety products, advancements in healthcare technologies, and the growing emphasis on environmentally friendly materials in various applications.

Daicel Financial Statement Overview

Summary

Daicel presents a sound financial standing with consistent revenue growth and healthy profit margins. The balance sheet is solid, though maintaining current debt levels is crucial. Cash flow generation has improved significantly, enhancing liquidity and financial flexibility.

Income Statement

Daicel shows strong financial performance with a consistent increase in total revenue over the years, reaching 586.5 billion JPY in 2025. The gross profit margin has remained robust, consistently above 27%. The net profit margin, while slightly fluctuating, is solid at 8.4% for 2025. Revenue growth rate from 2024 to 2025 is 5.1%, indicating steady growth. EBIT and EBITDA margins are healthy, suggesting efficient operating performance.

Balance Sheet

The balance sheet reflects a stable financial position with a debt-to-equity ratio at approximately 0.78, indicating moderate leverage. The equity ratio is 44.2%, reflecting a strong equity base. Return on equity (ROE) stands at 13.7% for 2025, showing efficient utilization of equity to generate profits. However, the high level of total debt at 280.9 billion JPY poses some risk if not managed properly.

Cash Flow

Daicel demonstrates positive cash flow trends, with free cash flow growing significantly from 2024 to 2025, marking a 211.7% increase. The operating cash flow to net income ratio is 1.89, indicating strong cash conversion efficiency. The free cash flow to net income ratio at 0.47 suggests adequate cash generation relative to earnings, although there is room for improvement.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	580.23B	586.53B	558.06B	538.03B	467.94B	393.57B
Gross Profit	161.18B	164.75B	159.28B	145.81B	138.61B	111.43B
EBITDA	127.63B	108.86B	111.40B	79.08B	75.84B	61.01B
Net Income	42.91B	49.48B	55.83B	40.68B	31.25B	19.71B
Balance Sheet
Total Assets	839.85B	813.83B	839.17B	765.61B	698.84B	640.38B
Cash, Cash Equivalents and Short-Term Investments	68.82B	65.14B	73.18B	93.84B	90.53B	91.54B
Total Debt	300.82B	280.92B	299.79B	317.83B	280.50B	267.60B
Total Liabilities	461.74B	438.79B	464.31B	455.17B	419.29B	395.38B
Stockholders Equity	362.67B	359.99B	358.90B	295.21B	272.02B	237.85B
Cash Flow
Free Cash Flow	0.00	23.44B	7.52B	-25.08B	-4.48B	21.08B
Operating Cash Flow	0.00	93.41B	76.73B	26.85B	42.99B	57.87B
Investing Cash Flow	0.00	-47.87B	-55.37B	-44.09B	-46.53B	-34.22B
Financing Cash Flow	0.00	-48.85B	-52.37B	19.96B	-5.45B	-17.05B

Daicel Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 1252.50
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4202, the sentiment is Negative. The current price of 1252.5 is below the 20-day moving average (MA) of 1338.80, below the 50-day MA of 1348.26, and below the 200-day MA of 1261.94, indicating a bearish trend. The MACD of -17.77 indicates Positive momentum. The RSI at 33.50 is Neutral, neither overbought nor oversold. The STOCH value of 13.53 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:4202.

Daicel Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
4202	80 Outperform	$352.46B	8.37	9.34%	4.53%	-0.48%	-35.29%
4182	77 Outperform	$549.88B	13.28	6.42%	3.53%	-6.27%	40.98%
4205	72 Outperform	$317.10B	8.80	9.65%	4.21%	0.87%	16.71%
4088	69 Neutral	$495.98B	9.95	10.06%	3.12%	4.35%	7.88%
4203	68 Neutral	€445.01B	22.69	6.52%	1.85%	3.25%	-11.31%
4183	62 Neutral	$693.99B	45.90	1.78%	4.16%	-0.91%	-74.07%
Sector *	61 Neutral	$10.43B	7.12	-0.05%	2.87%	2.86%	-36.73%

Daicel Corporate Events

Daicel Corporation Announces Strategic Reorganization with Polyplastics

Daicel Corporation announced a reorganization plan involving the absorption of its subsidiary, Polyplastics Co., Ltd., to streamline operations and enhance its engineering plastics business. This move aligns with Daicel’s medium-term strategy to transform its business structure, aiming to integrate Polyplastics’ strengths and improve corporate efficiency, ultimately maximizing corporate value.

The most recent analyst rating on (JP:4202) stock is a Buy with a Yen1505.00 price target. To see the full list of analyst forecasts on Daicel stock, see the JP:4202 Stock Forecast page.

Daicel Completes Treasury Stock Disposal for Employee Incentive Plan

Daicel Corporation announced the completion of payment procedures for the disposal of treasury stock as part of a Restricted Stock Incentive Plan for its Employee Shareholding Associations. The number of shares and total value of the disposal were adjusted due to partial forfeiture, reflecting the finalized consent of ESA members to the plan.

The most recent analyst rating on (JP:4202) stock is a Hold with a Yen1340.00 price target. To see the full list of analyst forecasts on Daicel stock, see the JP:4202 Stock Forecast page.

Daicel Completes Treasury Stock Disposal for Compensation Plan

Daicel Corporation has completed the disposal of its treasury stock as part of a restricted stock compensation plan, following a resolution made at the Board of Directors’ meeting on July 17, 2025. The disposal involved 167,708 shares at a price of 1,249.5 yen per share, with a total value of 209,551,146 yen, distributed among the company’s board directors, executive officers, and corporate officers.

The most recent analyst rating on (JP:4202) stock is a Hold with a Yen1510.00 price target. To see the full list of analyst forecasts on Daicel stock, see the JP:4202 Stock Forecast page.

Daicel Reports Decline in Q1 2025 Financial Results but Maintains Year-End Forecast

Daicel Corporation reported a decline in its financial performance for the three months ended June 30, 2025, with net sales decreasing by 4.3% and profit attributable to owners of the parent dropping by 40.6% compared to the previous year. Despite the downturn, the company maintains its forecast for the fiscal year ending March 31, 2026, expecting a slight increase in net sales and a recovery in profits, indicating a strategic focus on stabilizing its financial position.

The most recent analyst rating on (JP:4202) stock is a Hold with a Yen1400.00 price target. To see the full list of analyst forecasts on Daicel stock, see the JP:4202 Stock Forecast page.